TNA
True North Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
54,716
-2,139
| -4% | -$51.9K | 0.25% | 76 |
|
|
2025
Q1 | $1.44M | Buy |
56,855
+4,267
| +8% | +$108K | 0.26% | 81 |
|
|
2024
Q4 | $1.4M | Buy |
52,588
+666
| +1% | +$17.7K | 0.33% | 52 |
|
|
2024
Q3 | $1.5M | Sell |
51,922
-1,461
| -3% | -$42.3K | 0.39% | 42 |
|
|
2024
Q2 | $1.49M | Buy |
53,383
+510
| +1% | +$14.3K | 0.4% | 38 |
|
|
2024
Q1 | $1.47M | Sell |
52,873
-1,129
| -2% | -$31.3K | 0.41% | 40 |
|
|
2023
Q4 | $1.55M | Buy |
54,002
+423
| +0.8% | +$12.2K | 0.4% | 41 |
|
|
2023
Q3 | $1.78M | Sell |
53,579
-592
| -1% | -$19.6K | 0.55% | 34 |
|
|
2023
Q2 | $1.99M | Sell |
54,171
-22,690
| -30% | -$832K | 0.56% | 39 |
|
|
2023
Q1 | $3.14M | Sell |
76,861
-5,752
| -7% | -$235K | 0.92% | 19 |
|
|
2022
Q4 | $4.23M | Buy |
82,613
+781
| +1% | +$40K | 1.44% | 13 |
|
|
2022
Q3 | $3.58M | Sell |
81,832
-469
| -0.6% | -$20.5K | 1.17% | 14 |
|
|
2022
Q2 | $4.32M | Buy |
82,301
+115
| +0.1% | +$6.03K | 1.34% | 12 |
|
|
2022
Q1 | $4.25M | Sell |
82,186
-2,004
| -2% | -$104K | 1.14% | 14 |
|
|
2021
Q4 | $4.97M | Buy |
84,190
+5,529
| +7% | +$326K | 0.84% | 21 |
|
|
2021
Q3 | $3.38M | Buy |
78,661
+2,432
| +3% | +$105K | 0.67% | 32 |
|
|
2021
Q2 | $2.99M | Sell |
76,229
-591
| -0.8% | -$23.1K | 0.62% | 36 |
|
|
2021
Q1 | $2.78M | Buy |
76,820
+126
| +0.2% | +$4.57K | 0.66% | 33 |
|
|
2020
Q4 | $2.82M | Sell |
76,694
-8,292
| -10% | -$305K | 0.72% | 34 |
|
|
2020
Q3 | $3.12M | Buy |
84,986
+2,436
| +3% | +$89.4K | 0.91% | 27 |
|
|
2020
Q2 | $2.7M | Buy |
82,550
+12,263
| +17% | +$401K | 0.65% | 35 |
|
|
2020
Q1 | $2.29M | Buy |
70,287
+1,018
| +1% | +$33.2K | 0.78% | 32 |
|
|
2019
Q4 | $2.71M | Buy |
+69,269
| New | +$2.71M | 0.76% | 36 |
|